EQL Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is April - March.

Millions SEK. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	86.76	82.4	20.47	44.43	41.2
Cash & Short-Term Investments	86.76	82.4	20.47	44.43	41.2
Cash Growth	5.29%	302.58%	-53.93%	7.83%	55.01%
Accounts Receivable	92.74	130.72	60.77	51.7	34.1
Other Receivables	23.84	1.4	5.21	0.96	0.71
Receivables	116.58	132.12	65.98	52.66	34.81
Inventory	200.53	179.03	105.63	65.37	41.67
Prepaid Expenses	-	6.25	4.75	4.2	2.24
Other Current Assets	-	0.45	0.94	0.57	3.53
Total Current Assets	403.87	400.25	197.77	167.23	123.45
Property, Plant & Equipment	5.9	6.33	2.67	3.15	4.19
Long-Term Investments	-	0	0	0	0
Other Intangible Assets	441.11	364.67	149.08	102.54	98.41
Long-Term Deferred Charges	-	37.58	24.24	12.78	11.83
Other Long-Term Assets	0	-0	-	-	-
Total Assets	850.89	808.82	373.76	285.7	237.89
Accounts Payable	70.26	90.94	49.83	29.61	15.98
Accrued Expenses	-	10.29	6.65	17.87	16.28
Short-Term Debt	103.23	107.41	102.22	63.7	59.32
Current Portion of Long-Term Debt	-	4.11	-	-	5.4
Current Portion of Leases	-	2.75	1.4	1.21	-
Current Income Taxes Payable	-	-	-	0.14	-
Other Current Liabilities	36.75	1.53	1.43	4.66	1.64
Total Current Liabilities	210.23	221.02	162.05	117.19	98.76
Long-Term Debt	345.17	338.39	15.45	-	7.2
Long-Term Leases	-	3.05	1.02	1.71	4.18
Long-Term Deferred Tax Liabilities	28.43	25.34	17.51	12.05	4.12
Other Long-Term Liabilities	-0	0	-	0	-
Total Liabilities	583.83	587.79	196.03	130.94	114.26
Common Stock	267.06	1.31	1.31	1.31	1.31
Additional Paid-In Capital	-	67.64	67.45	67.18	66.99
Retained Earnings	-	152.08	108.97	86.26	55.33
Comprehensive Income & Other	-	-	-0	-	-
Shareholders' Equity	267.06	221.03	177.73	154.75	123.63
Total Liabilities & Equity	850.89	808.82	373.76	285.7	237.89
Total Debt	448.4	455.71	120.09	66.62	76.1
Net Cash (Debt)	-361.64	-373.31	-99.63	-22.19	-34.9
Net Cash Per Share	-11.99	-12.49	-3.34	-0.75	-1.20
Filing Date Shares Outstanding	29.53	29.06	29.06	29.06	29.06
Total Common Shares Outstanding	29.53	29.06	29.06	29.06	29.06
Working Capital	193.64	179.23	35.72	50.04	24.7
Book Value Per Share	9.04	7.61	6.12	5.32	4.25
Tangible Book Value	-174.06	-143.63	28.65	52.21	25.21
Tangible Book Value Per Share	-5.89	-4.94	0.99	1.80	0.87
Machinery	-	4.47	3.17	0.99	2.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.